Goldman Sachs’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,730
| Closed | -$274K | – | 4834 |
|
|
2023
Q2 | $274K | Hold |
11,730
| – | – | ﹤0.01% | 4272 |
|
|
2023
Q1 | $273K | Sell |
11,730
-9,719
| -45% | -$226K | ﹤0.01% | 4393 |
|
|
2022
Q4 | $540K | Buy |
21,449
+9,719
| +83% | +$245K | ﹤0.01% | 4052 |
|
|
2022
Q3 | $310K | Sell |
11,730
-38,354
| -77% | -$1.01M | ﹤0.01% | 4532 |
|
|
2022
Q2 | $1.45M | Buy |
50,084
+38,354
| +327% | +$1.11M | ﹤0.01% | 3686 |
|
|
2022
Q1 | $404K | Hold |
11,730
| – | – | ﹤0.01% | 4712 |
|
|
2021
Q4 | $514K | Buy |
+11,730
| New | +$514K | ﹤0.01% | 4503 |
|